Published in Brain Res on October 16, 1983
Modulation of cholecystokinin concentrations in the rat hippocampus by chelation of heavy metals. Proc Natl Acad Sci U S A (1984) 0.75
Rational design of potent, bioavailable, nonpeptide cyclic ureas as HIV protease inhibitors. Science (1994) 3.44
Pain intensity processing within the human brain: a bilateral, distributed mechanism. J Neurophysiol (1999) 3.27
Induction of a long-lasting AP-1 complex composed of altered Fos-like proteins in brain by chronic cocaine and other chronic treatments. Neuron (1994) 2.61
Analysis of the native quaternary structure of vanilloid receptor 1. J Biol Chem (2001) 2.55
Experimental pathogenicity of recent North American isolates of Yersinia enterocolitica. J Infect Dis (1974) 2.19
A modified polyriboinosinic-polyribocytidylic acid complex that induces interferon in primates. J Infect Dis (1975) 2.14
Cocaine induces striatal c-fos-immunoreactive proteins via dopaminergic D1 receptors. Proc Natl Acad Sci U S A (1991) 2.04
Prediction of peptide retention times in high-pressure liquid chromatography on the basis of amino acid composition. Proc Natl Acad Sci U S A (1980) 1.96
Physiological significance of alpha-adrenoceptor-mediated negative feedback mechanism regulating noradrenaline release during nerve stimulation. Nature (1977) 1.69
Rat brain phenolsulfotransferase: partial purification and some properties. Biochim Biophys Acta (1973) 1.64
Recombinant proteins attached to a nickel-NTA column: use in affinity purification of antibodies. Biotechniques (1994) 1.62
Genetic predictors for acute experimental cold and heat pain sensitivity in humans. J Med Genet (2006) 1.62
Substantia nigra: site of anticonvulsant activity mediated by gamma-aminobutyric acid. Science (1982) 1.60
Ligand-induced dynamic membrane changes and cell deletion conferred by vanilloid receptor 1. J Biol Chem (2000) 1.59
Genomic integration and gene expression by a modified adenoviral vector. Nat Biotechnol (2000) 1.55
Resistance to HIV protease inhibitors: a comparison of enzyme inhibition and antiviral potency. Biochemistry (1998) 1.43
Inositol bis-, tris-, and tetrakis(phosphate)s: analysis in tissues by HPLC. Proc Natl Acad Sci U S A (1986) 1.38
Hemispheric lateralization of somatosensory processing. J Neurophysiol (2001) 1.35
Excitatory amino acid recognition sites coupled with inositol phospholipid metabolism: developmental changes and interaction with alpha 1-adrenoceptors. Proc Natl Acad Sci U S A (1986) 1.34
Coupling of inositol phospholipid metabolism with excitatory amino acid recognition sites in rat hippocampus. J Neurochem (1986) 1.26
Anandamide activates vanilloid receptor 1 (VR1) at acidic pH in dorsal root ganglia neurons and cells ectopically expressing VR1. J Biol Chem (2001) 1.26
Acetylcholine and choline in neuronal tissue measured by HPLC with electrochemical detection. J Neurochem (1983) 1.23
Chronic alterations in dopaminergic neurotransmission produce a persistent elevation of deltaFosB-like protein(s) in both the rodent and primate striatum. Eur J Neurosci (1996) 1.20
In situ hybridization histochemistry and immunocytochemistry reveal an increase in spinal dynorphin biosynthesis in a rat model of peripheral inflammation and hyperalgesia. Proc Natl Acad Sci U S A (1988) 1.14
A paracrine paradigm for in vivo gene therapy in the central nervous system: treatment of chronic pain. Hum Gene Ther (1999) 1.13
Spinal opioid analgesic effects are enhanced in a model of unilateral inflammation/hyperalgesia: possible involvement of noradrenergic mechanisms. Eur J Pharmacol (1991) 1.09
Cloning of a DNA binding protein that is a tyrosine kinase substrate and recognizes an upstream initiator-like sequence in the promoter of the preprodynorphin gene. Brain Res Mol Brain Res (1994) 1.07
Improved cyclic urea inhibitors of the HIV-1 protease: synthesis, potency, resistance profile, human pharmacokinetics and X-ray crystal structure of DMP 450. Chem Biol (1996) 1.06
Rat brain protein kinase C: purification, antibody production, and quantification in discrete regions of hippocampus. J Neurochem (1989) 1.05
Monocyte chemoattractant protein-1 in the choroid plexus: a potential link between vascular pro-inflammatory mediators and the CNS during peripheral tissue inflammation. Neuroscience (2008) 1.05
Temporal analysis of increases in c-fos, preprodynorphin and preproenkephalin mRNAs in rat spinal cord. Brain Res Mol Brain Res (1989) 1.04
Dynorphin expression and Fos-like immunoreactivity following inflammation induced hyperalgesia are colocalized in spinal cord neurons. Brain Res Mol Brain Res (1991) 1.04
Dynorphin increases in the dorsal spinal cord in rats with a painful peripheral neuropathy. Peptides (1990) 1.02
Up-regulation of opioid gene expression in spinal cord evoked by experimental nerve injuries and inflammation. Brain Res (1991) 1.00
Fluorometric estimation of 4-hydroxy-3-methoxyphenylethyleneglycol sulphate in brain. Br J Pharmacol (1972) 0.99
Fos-like proteins in the lumbosacral spinal cord following noxious and non-noxious colorectal distention in the rat. Pain (1992) 0.99
Demonstration of inositol 1,3,4,5-tetrakisphosphate receptor binding. Biochem Biophys Res Commun (1987) 0.99
Salivary anti-Ro60 and anti-Ro52 antibody profiles to diagnose Sjogren's Syndrome. J Dent Res (2011) 0.98
Stress selectively increases fos protein in dopamine neurons innervating the prefrontal cortex. Cereb Cortex (1992) 0.97
Isolation, characterization, and purification to homogeneity of a rat brain protein (GABA-modulin). Proc Natl Acad Sci U S A (1982) 0.97
Transcription factor regulation of prodynorphin gene expression following rat hindpaw inflammation. Brain Res Mol Brain Res (1998) 0.96
Enkephalin biosynthesis in adrenal medulla. Modulation of proenkephalin mRNA content of cultured chromaffin cells by 8-bromo-adenosine 3',5'-monophosphate. Mol Pharmacol (1984) 0.94
Regionally specific effects of atypical antipsychotic drugs on striatal Fos expression: The nucleus accumbens shell as a locus of antipsychotic action. Mol Cell Neurosci (1992) 0.93
Patterns of epithelial expression of Fos protein suggest important role in the transition from viable to cornified cell during keratinization. Development (1991) 0.93
Pentylenetetrazol-induced kindling in rats: effect of GABA function inhibitors. Pharmacol Biochem Behav (1991) 0.93
The rate of formation of 3-methoxy-4-hydroxyphenylethyleneglycol sulfate in brain as an estimate of the rate of formation of norepinephrine. J Pharmacol Exp Ther (1973) 0.92
Occurrence and localization of brain phenolsulphotransferase. J Neurochem (1974) 0.91
Is cerebrospinal fluid the major avenue for the removal of 5-hydroxyindoleacetic acid from the brain? Neuropharmacology (1973) 0.91
Adenoviral gene transfer to spinal-cord neurons: intrathecal vs. intraparenchymal administration. Brain Res (1998) 0.90
Decrease in the function of the gamma-aminobutyric acid-coupled chloride channel produced by the repeated administration of pentylenetetrazol to rats. J Neurochem (1990) 0.89
Effects of D2 dopamine receptor antagonists on Fos protein expression in the striatal complex and entorhinal cortex of the nonhuman primate. Synapse (1996) 0.89
Behavior of the Roman/Verh high- and low-avoidance rat lines in anxiety tests: relationship with defecation and self-grooming. Physiol Behav (1995) 0.89
Changes in dynorphin, enkephalin and cholecystokinin content of hippocampus and substantia nigra after amygdala kindling. Brain Res (1986) 0.89
Potency and selectivity of inhibition of human immunodeficiency virus protease by a small nonpeptide cyclic urea, DMP 323. Antimicrob Agents Chemother (1994) 0.89
Cellular compartments of GABA in brain and their relationship to anticonvulsant activity. Mol Cell Biochem (1981) 0.88
UREB1, a tyrosine phosphorylated nuclear protein, inhibits p53 transactivation. Oncogene (1995) 0.88
Actions of intrathecal diphtheria toxin-substance P fusion protein on models of persistent pain. Pain (1999) 0.88
Genetic selection and differential stress responses. The Roman lines/strains of rats. Ann N Y Acad Sci (1998) 0.87
Epidural resiniferatoxin induced prolonged regional analgesia to pain. Brain Res (1999) 0.87
Evidence for a tonic GABAergic control of serotonin neurons in the median raphe nucleus. Brain Res (1981) 0.87
Seizure protection and increased nerve-terminal GABA: delayed effects of GABA transaminase inhibition. Science (1980) 0.87
Enkephalin catabolism in vitro and in vivo. Neuropharmacology (1977) 0.87
Basal and inducible transcriptional activity of an upstream AP-1/CRE element (DYNCRE3) in the prodynorphin promoter. Mol Cell Neurosci (1994) 0.86
Peripheral inflammation is associated with increased dynorphin immunoreactivity in both projection and local circuit neurons in the superficial dorsal horn of the rat lumbar spinal cord. Neurosci Lett (1989) 0.86
Differential induction of Fos protein and a Fos-related antigen following acute and repeated cocaine administration. Brain Res Mol Brain Res (1994) 0.85
Fos-like immunoreactivity increases in the lumbar spinal cord following a chronic constriction injury to the sciatic nerve of rat. Neurosci Lett (1996) 0.85
c-Fos expression in NMDA receptor-contained neurons in spinal cord in a rat model of inflammation: a double immunocytochemical study. Brain Res (1998) 0.85
Immunohistochemical localization of N-methyl-D-aspartate and alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionate receptor subunits in the substantia nigra pars compacta of the rat. Neuroscience (1999) 0.84
Catecholamines: diminished rate of synth- esis in rat brain and heart after thyroxine pretreatment. Life Sci I (1970) 0.84
Rapid plasmid DNA sequencing with multiple octamer primers. Biotechniques (1994) 0.84
Spinal cord genes enriched in rat dorsal horn and induced by noxious stimulation identified by subtraction cloning and differential hybridization. Neuroscience (2001) 0.83
Serotonin and gamma-aminobutyric acid turnover after injection into the median raphe of substance P and D-ala-met-enkephalin amide. J Neurochem (1982) 0.82
New technologies for studying the complexity of oral diseases. Oral Dis (2011) 0.82
Long-lasting proconflict effect induced by chronic administration of the beta-carboline derivative FG 7142. Neurosci Lett (1985) 0.82
Co-localization of N-methyl-D-aspartate receptors and substance P (neurokinin-1) receptors in rat spinal cord. Neurosci Lett (2000) 0.82
Spinal kappa1 and kappa2 opioid binding sites in rats, guinea pigs, monkeys and humans. Neuroreport (1998) 0.82
GABAergic and dopaminergic transmission in the rat cerebral cortex: effect of stress, anxiolytic and anxiogenic drugs. Pharmacol Ther (1990) 0.82
Intrathecally administered cholera toxin blocks allodynia and hyperalgesia in persistent pain models. J Pain (2001) 0.82
Effect of multiple dorsal rhizotomies on calcitonin gene-related peptide-like immunoreactivity in the lumbosacral dorsal spinal cord of the cat: a radioimmunoassay analysis. Peptides (1990) 0.82
GR89,696 is a kappa-2 opioid receptor agonist and a kappa-1 opioid receptor antagonist in the guinea pig hippocampus. J Pharmacol Exp Ther (1997) 0.82
Electrical stimulation of visceral afferent pathways in the pelvic nerve increases c-fos in the rat lumbosacral spinal cord. Neurosci Lett (1991) 0.82
Nonpeptide cyclic cyanoguanidines as HIV-1 protease inhibitors: synthesis, structure-activity relationships, and X-ray crystal structure studies. J Med Chem (1998) 0.81
Stimulation of adrenal medullary cells in vivo and in vitro induces expression of c-fos proto-oncogene. Oncogene (1990) 0.81
Global cerebral blood flow decreases during pain. J Cereb Blood Flow Metab (1998) 0.81
Modulation of brain tryptophan hydroxylase activity by brain tryptophan content. J Pharmacol Exp Ther (1977) 0.81
NMDAR1 glutamate receptor subunit isoforms in neostriatal, neocortical, and hippocampal nitric oxide synthase neurons. J Neurosci (1998) 0.81
An isobolographic analysis of the effects of N-methyl-D-aspartate and NK1 tachykinin receptor antagonists on inflammatory hyperalgesia in the rat. Br J Pharmacol (1996) 0.81
Analgesic activity and release of [MET5]enkephalin-Arg6-Gly7-Leu8 from rat spinal cord in vivo. Eur J Pharmacol (1986) 0.80
A reduction of the tone of 5-hydroxytryptamine neurons decreases utilization rates of striatal and hypothalamic enkephalins. Eur J Pharmacol (1984) 0.80
A kinetic analysis of substance P trafficking. J Pharm Sci (2003) 0.80
Localization of alternatively spliced NMDAR1 glutamate receptor isoforms in rat striatal neurons. J Comp Neurol (1999) 0.80
Dorsal root ganglia and nerve growth factor: a model for understanding the mechanism of GM1 effects on neuronal repair. J Neurosci Res (1984) 0.80
Tryptophan 5-hydroxylase: approximation of half-life and rate of axonal transport. J Neurochem (1972) 0.80
Chronic tooth pulp inflammation causes transient and persistent expression of Fos in dynorphin-rich regions of rat brainstem. Brain Res (2000) 0.79
Ornithine as a precursor of neurotransmitter glutamate: effect of canaline on ornithine aminotransferase activity and glutamate content in the septum of rat brain. Brain Res (1985) 0.79
Changes in the dynamic state of brain proenkephalin-derived peptides during amygdaloid kindling. J Neurosci Res (1986) 0.79
Substance P antagonists in substantia nigra are anticonvulsant. Brain Res (1986) 0.79